S. Alice Long

8.7k total citations · 2 hit papers
79 papers, 4.1k citations indexed

About

S. Alice Long is a scholar working on Immunology, Genetics and Surgery. According to data from OpenAlex, S. Alice Long has authored 79 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Immunology, 41 papers in Genetics and 20 papers in Surgery. Recurrent topics in S. Alice Long's work include Diabetes and associated disorders (39 papers), Immune Cell Function and Interaction (39 papers) and T-cell and B-cell Immunology (31 papers). S. Alice Long is often cited by papers focused on Diabetes and associated disorders (39 papers), Immune Cell Function and Interaction (39 papers) and T-cell and B-cell Immunology (31 papers). S. Alice Long collaborates with scholars based in United States, Australia and China. S. Alice Long's co-authors include Jane H. Buckner, Carla J. Greenbaum, Kevan C. Herold, Gerald T. Nepom, Karen Cerosaletti, Mary Rieck, Peter S. Linsley, Jeffrey A. Bluestone, Paul L. Bollyky and Shipra Gupta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

S. Alice Long

75 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

2015 810 citations Jane H. Buckner, Kevan C. Herold et al. Science Translational Medicine profile →
Free-surface jetting driven by a cavitating vortex ring

2025 35 citations S. Alice Long et al. profile →

Peers

S. Alice Long

IMMUN

GENET

SURGE

EDM

ONCOL

Ola Winqvist Sweden

Deborah Phippard United States

Alessandra Fierabracci Italy

Claudio Pignata Italy

Charles Thivolet France

Dag E. Undlien Norway

H Nagura Japan

Marcello Bagnasco Italy

Benedicte A. Lie Norway

Vito Lampasona Italy

Ola Winqvist Sweden

S. Alice Long

2.1k ×0.9

IMMUN

749 ×0.5

GENET

598 ×0.6

SURGE

796 ×1.0

EDM

853 ×1.3

ONCOL

Citations per year, relative to S. Alice Long S. Alice Long (= 1×) peers Ola Winqvist

Countries citing papers authored by S. Alice Long

Since Specialization

Citations

This map shows the geographic impact of S. Alice Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Alice Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Alice Long more than expected).

Fields of papers citing papers by S. Alice Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Alice Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Alice Long. The network helps show where S. Alice Long may publish in the future.

Co-authorship network of co-authors of S. Alice Long

This figure shows the co-authorship network connecting the top 25 collaborators of S. Alice Long. A scholar is included among the top collaborators of S. Alice Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Alice Long. S. Alice Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lemaître, Pierre, Francesca Lodi, Niels Vandamme, et al.. (2025). Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes. Journal of Clinical Investigation. 135(23).

Preston‐Hurlburt, Paula, Pamela Clark, Peter S. Linsley, et al.. (2024). Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes. Journal of Clinical Investigation. 134(18). 17 indexed citations

Mallone, Roberto, Emily K. Sims, Peter Achenbach, et al.. (2024). Emerging Concepts and Success Stories in Type 1 Diabetes Research: A Road Map for a Bright Future. Diabetes. 74(1). 12–21. 3 indexed citations

Mathieu, Chantal, Alice Wiedeman, Karen Cerosaletti, et al.. (2023). A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab. Diabetologia. 67(1). 27–41. 38 indexed citations

Jacobsen, Laura M., Kirsten E. Diggins, Lori Blanchfield, et al.. (2023). Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes. JCI Insight. 8(16). 26 indexed citations

Sims, Emily K., Susan Geyer, S. Alice Long, & Kevan C. Herold. (2023). High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment. Diabetologia. 66(12). 2283–2291. 6 indexed citations

Bolouri, Hamid, Rhonda E. Ries, Alice Wiedeman, et al.. (2022). Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes. Nature Communications. 13(1). 7186–7186. 3 indexed citations

Bolouri, Hamid, Cate Speake, David Skibinski, et al.. (2021). The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity. Journal of Clinical Investigation. 131(3). 22 indexed citations

Marwaha, Ashish, Anne M. Pesenacker, Laura Cook, et al.. (2021). A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes. PubMed. 2(1). ltab022–ltab022. 16 indexed citations

10.

Rasouli, Javad, Giacomo Casella, Satoshi Yoshimura, et al.. (2020). A distinct GM-CSF ⁺ T helper cell subset requires T-bet to adopt a T _H 1 phenotype and promote neuroinflammation. Science Immunology. 5(52). 39 indexed citations

11.

Speake, Cate, Samuel O. Skinner, Dror Berel, et al.. (2019). A composite immune signature parallels disease progression across T1D subjects. JCI Insight. 4(23). 12 indexed citations

12.

Wiedeman, Alice, Mario G. Rosasco, Hannah A. DeBerg, et al.. (2019). Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression. Journal of Clinical Investigation. 130(1). 480–490. 125 indexed citations

13.

Lord, James D., S. Alice Long, Donna Shows, et al.. (2018). Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype. Clinical Immunology. 193. 24–32. 21 indexed citations

14.

Morrell, Eric D., Alice Wiedeman, S. Alice Long, et al.. (2018). Cytometry TOF identifies alveolar macrophage subtypes in acute respiratory distress syndrome. JCI Insight. 3(10). 36 indexed citations

15.

Perdigoto, Ana Luisa, Paula Preston‐Hurlburt, Pamela Clark, et al.. (2018). Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis. Diabetologia. 62(4). 655–664. 85 indexed citations

16.

Long, S. Alice, Jerill Thorpe, Kevan C. Herold, et al.. (2017). Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes. Cellular Immunology. 319. 3–9. 62 indexed citations

17.

Long, S. Alice, et al.. (2014). Opioid Misuse Behaviors in Adolescents and Young Adults in a Hematology/Oncology Setting. Journal of Pediatric Psychology. 39(10). 1149–1160. 36 indexed citations

18.

Schneider, Anya, S. Alice Long, Karen Cerosaletti, et al.. (2013). In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive T _regs Involves IL-6–Mediated Signaling. Science Translational Medicine. 5(170). 170ra15–170ra15. 130 indexed citations

19.

Schneider, Anya, S. Alice Long, Mariko Kita, & Jane H. Buckner. (2009). Persistence of FOXP3 expression is impaired in RR-MS Tregs (99.3). The Journal of Immunology. 182(Supplement_1). 99.3–99.3. 1 indexed citations

20.

Long, S. Alice, Mindi Walker, Mary Rieck, et al.. (2009). Functional islet‐specific Treg can be generated from CD4⁺CD25⁻ T cells of healthy and type 1 diabetic subjects. European Journal of Immunology. 39(2). 612–620. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact